These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 17681761

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Comments on 'The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia'.
    Hashimoto K.
    J Psychopharmacol; 2010 Jul; 24(7):1133-4. PubMed ID: 19939869
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Pharmacological stimulation of NMDA receptors via co-agonist site suppresses fMRI response to phencyclidine in the rat.
    Gozzi A, Herdon H, Schwarz A, Bertani S, Crestan V, Turrini G, Bifone A.
    Psychopharmacology (Berl); 2008 Dec; 201(2):273-84. PubMed ID: 18704372
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating.
    Fradley RL, O'Meara GF, Newman RJ, Andrieux A, Job D, Reynolds DS.
    Behav Brain Res; 2005 Sep 08; 163(2):257-64. PubMed ID: 16046005
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [Phencyclidine--angel dust].
    Høiseth G, Hjelmeland K, Bachs L.
    Tidsskr Nor Laegeforen; 2005 Oct 20; 125(20):2775-6. PubMed ID: 16244678
    [Abstract] [Full Text] [Related]

  • 50. The importance of nitric oxide in social dysfunction.
    Wass C, Klamer D, Fejgin K, Pålsson E.
    Behav Brain Res; 2009 Jun 08; 200(1):113-6. PubMed ID: 19166879
    [Abstract] [Full Text] [Related]

  • 51. N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives.
    Millan MJ.
    Psychopharmacology (Berl); 2005 Apr 08; 179(1):30-53. PubMed ID: 15761697
    [Abstract] [Full Text] [Related]

  • 52. Drug discovery strategies and the preclinical development of D-amino-acid oxidase inhibitors as antipsychotic therapies.
    Szilágyi B, Ferenczy GG, Keserű GM.
    Expert Opin Drug Discov; 2018 Oct 08; 13(10):973-982. PubMed ID: 30220232
    [Abstract] [Full Text] [Related]

  • 53. Identification of novel D-amino acid oxidase inhibitors by in silico screening and their functional characterization in vitro.
    Katane M, Osaka N, Matsuda S, Maeda K, Kawata T, Saitoh Y, Sekine M, Furuchi T, Doi I, Hirono S, Homma H.
    J Med Chem; 2013 Mar 14; 56(5):1894-907. PubMed ID: 23391306
    [Abstract] [Full Text] [Related]

  • 54. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo.
    Millan MJ, Svenningsson P, Ashby CR, Hill M, Egeland M, Dekeyne A, Brocco M, Di Cara B, Lejeune F, Thomasson N, Munoz C, Mocaër E, Crossman A, Cistarelli L, Girardon S, Iob L, Veiga S, Gobert A.
    J Pharmacol Exp Ther; 2008 Feb 14; 324(2):600-11. PubMed ID: 18024787
    [Abstract] [Full Text] [Related]

  • 55. A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats.
    Manahan-Vaughan D, von Haebler D, Winter C, Juckel G, Heinemann U.
    Hippocampus; 2008 Feb 14; 18(2):125-34. PubMed ID: 17924525
    [Abstract] [Full Text] [Related]

  • 56. D-aspartate dysregulation in Ddo(-/-) mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum.
    de Bartolomeis A, Errico F, Aceto G, Tomasetti C, Usiello A, Iasevoli F.
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Oct 01; 62():35-43. PubMed ID: 25979765
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and D-serine.
    Hashimoto K, Fujita Y, Ishima T, Chaki S, Iyo M.
    Eur Neuropsychopharmacol; 2008 Jun 01; 18(6):414-21. PubMed ID: 17804206
    [Abstract] [Full Text] [Related]

  • 60. Depletion of cerebral D-serine in non-ketotic hyperglycinemia: possible involvement of glycine cleavage system in control of endogenous D-serine.
    Iwama H, Takahashi K, Kure S, Hayashi F, Narisawa K, Tada K, Mizoguchi M, Takashima S, Tomita U, Nishikawa T.
    Biochem Biophys Res Commun; 1997 Feb 24; 231(3):793-6. PubMed ID: 9070895
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.